Waters Micromass ZQ

One Bench at a Time

Waters Micromass ZQ

The Waters Micromass® ZQ™ Mass Spectrometer, the most popular single quadrupole mass spectrometer worldwide, offers characteristic performance and robustness for laboratories that require nominal mass resolution for mass confirmation applications.

Also in-house: the associated in-line chromatography unit, model 2695.

Powerful Technology Platform

The ZQ Mass Spectrometer is built using the technical innovation you expect from Micromass brand products. The ZQ’s distinctive features include:

  • Small footprint (Width x Height x Depth): 390 mm x 587 mm x 810 mm (15.3 in x 23.1 in x 32.0 in)
  • 2040 or 4096 amu upper mass limit
  • Acquisition rates up to 5000 amu/sec using a state-of-the-art Embedded Personal Computer Acquisition System (EPCAS™)
  • ZSpray™ dual orthogonal sampling interface provides unsurpassed sensitivity and ruggedness
  • Vertically mounted liquid inlet probes to minimize tube length and peak dispersion
  • Software-controlled, integrated syringe pump for easy calibration, tuning and sample infusion
  • Software-controlled divert valve/manual injection valve
  • Digital control of source gas flow rates
  • Differentially pumped vacuum system featuring singular air-cooled, split flow turbomolecular pump technology
  • Control and data acquisition with MassLynx, Empower and Millennium®32 4.0 Software

Upcoming Event

  • Reaction before action: new approaches to biomineralization-associated diseases

    12:30-13:30
    10/19/2017
    Daniel Laser, PhD CEO and Co-Founder, Applaud Medical RSVP Applaud Medical is a three-year-old company developing treatments for biomineralization-related diseases. Applaud's products use violent physical effects like cavitation and shock waves to achieve a therapeutic effect, while sparing non-targeted tissue through precise chemical targeting. Applaud's lead product, for low-invasiveness treatment of kidney stones, is currently in clinical trials in Gujarat, India. This seminar will cover technical aspects of combining chemical reactions with mechanical action in both Applaud's products and in a range of other drugs and devices, along with a brief discussion of key commercialization considerations for this uniquely promising product category. About Daniel Laser Daniel Laser is Chief Executive Officer and co-founder of Applaud Medical. Dan also founded Wave 80 Biosciences, a pioneer in detecting HIV during the high-transmission-risk earliest phase of infection, when the immune response is insufficiently advanced for antibody-based methods. He has served as board member or advisor to drug and device companies in fields ranging from autoimmune disease to ophthalmology to cancer. Dan got his start in the medical device field working on haptic feedback for telerobotic surgery systems. Dan holds a Ph.D. in mechanical engineering from Stanford University, where he was a Semiconductor Research Corporation Graduate Fellow. While at Stanford, he was also a MacArthur Affiliate at Stanford’s Center for International Security and Cooperation, developing mathematical models for protecting against threats involving weaponized pathogens.

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter